J St Clair Roberts

Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.

Andreas M. Kaufmann, Peter L. Stern, Elaine M. Rankin et al. · PubMed · 2002 · 204 citations

Human therapeutic cocaine vaccine: safety and immunogenicity

Thomas R. Kosten, Marc I. Rosen, Julian F. Bond et al. · Vaccine · 2002 · 192 citations

Vaccination, Mucosal Vaccination, Immunology +3

Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia.

Peter Baldwin, Sjoerd H. van der Burg, Christopher M. Boswell et al. · PubMed · 2003 · 174 citations

Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.

Emma J. Davidson, Christopher M. Boswell, Peter Sehr et al. · PubMed · 2003 · 171 citations

Immunology, Gynecology, Pathology +21

Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine

Annemieke de Jong, Terence W O’Neill, A.Y Khan et al. · Vaccine · 2002 · 165 citations

Vaccination, Vaccine Development, Cervical Cancer +11